Patent details

LUC00248 Product Name: Vosoritide sous toutes les formes protégées par le brevet de base

Basic Information

Publication number:
LUC00248
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP107783896
Legal Status:
Inactive
Application number:
LUC00248
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/21/1577
Marketing Authorization Type:
Marketing Authorization Date:
01/09/2021
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
24/01/2022
First Marketing Authorization date:
01/09/2021
Grant date:
04/03/2025
Activation date:
Publication date:
24/01/2022
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
20/05/2035
SPC Extension Expiration:
20/05/2035
Rejection date:
Withdrawal date:

Owner

From:
24/01/2022
 
 

Name:
BioMarin Pharmaceutical Inc.
Address:
105 Digital Drive, Novato, CA 94949, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
24/01/2022
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2022/02
Publication date:
01/02/2022
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2025/05
Publication date:
07/04/2025
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
31/05/2030
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
24/01/2022 Marketing authorization 3
24/01/2022 Summary of the product caracteristics 54
24/01/2022 Application Form 3
24/01/2022 Outgoing Correspondence 1
24/01/2022 MA publication 8
24/01/2022 Publication 1
04/03/2025 Publication 1
04/03/2025 Certificate 1
04/03/2025 Outgoing Correspondence 1